Murata H, Kusuzaki K, Takeshita H, Hirata M, Hashiguchi S, Ashihara T, Hirasawa Y
Department of Orthopaedic Surgery, Kyoto Prefectural University of Medicine, Japan.
Cancer Lett. 1999 Mar 1;136(2):223-9. doi: 10.1016/s0304-3835(98)00325-5.
DNA ploidy analysis by DNA cytofluorometry was performed on 41 tumors obtained from 37 patients with primary giant cell tumor of bone (GCT). Histologically, 26 of the tumors from primary or recurrent lesions were evaluated as grade I, and 13 tumors as grade II. Among the 33 primary GCT patients, 4 patients had local recurrence or pulmonary metastasis. The DNA ploidy pattern and the percentage of hyperdiploid cells showing a greater DNA content than diploid cells, were obtained from DNA cytofluorometry. All of the 33 primary tumors were diploid. Of 6 recurrent tumors, 4 were diploid and 2 were euploid-polyploid. One of the two pulmonary metastatic tumors was diploid, but another that demonstrated a malignant transformation to malignant fibrous histiocytoma was aneuploid. The percentage of hyperdiploid cells was significantly different between primary and recurrent tumors (P = 0.0188) and between grade I and grade II tumors (P = 0.0052), while there was no difference between primary tumors in the cases that recurred or metastasized and those that did not. Thus, these data indicate that cell proliferative activity is closely correlated with biological aggressiveness and histological grading, although DNA ploidy is not useful for predicting prognosis.
对37例原发性骨巨细胞瘤(GCT)患者的41个肿瘤进行了DNA细胞荧光测定法的DNA倍体分析。组织学上,26个来自原发性或复发性病变的肿瘤被评估为I级,13个肿瘤为II级。在33例原发性GCT患者中,4例出现局部复发或肺转移。通过DNA细胞荧光测定法获得了DNA倍体模式以及显示DNA含量高于二倍体细胞的超二倍体细胞百分比。所有33个原发性肿瘤均为二倍体。6个复发性肿瘤中,4个为二倍体,2个为整倍体-多倍体。两个肺转移瘤中,一个为二倍体,但另一个已恶变成为恶性纤维组织细胞瘤,为非整倍体。原发性肿瘤和复发性肿瘤之间(P = 0.0188)以及I级和II级肿瘤之间(P = 0.0052)超二倍体细胞百分比存在显著差异,而复发或转移病例与未复发或转移病例的原发性肿瘤之间无差异。因此,这些数据表明,尽管DNA倍体对预测预后无用,但细胞增殖活性与生物学侵袭性和组织学分级密切相关。